chronic kidney disease

ProKidney halts one CKD cell therapy phase 3 trial considered surplus to FDA approval
Fierce Biotech
Tue, 09/3/24 - 11:19 am
ProKidney
cell therapy
chronic kidney disease
rilparencel
Chronic kidney disease market estimated to grow at 19.6%, driven by pipeline agents aimed at unmet needs
Clinical Trials Arena
Fri, 06/21/24 - 11:49 am
chronic kidney disease
Novo Nordisk doses first subject in Phase I trial of NLRP3 inhibitor
Clinical Trials Arena
Mon, 05/6/24 - 11:38 am
Novo Nordisk
NLRP3 inhibitors
NNC6022-0001
VENT-01
clinical trials
MASH
NASH
chronic kidney disease
FDA approves Akebia's anemia drug
Reuters
Wed, 03/27/24 - 10:32 pm
Akebia
FDA
vadadustat
chronic kidney disease
Novo kidney trial finds Ozempic cuts cardiac risks in diabetics
Reuters
Tue, 03/5/24 - 11:52 am
Novo Nordisk
Ozempic
clinical trials
diabetes
chronic kidney disease
AstraZeneca's failed cancer drug gets new lease on life thanks to positive kidney disease data
Fierce Biotech
Fri, 11/3/23 - 11:55 am
AstraZeneca
zibotentan
chronic kidney disease
FDA approves Ardelyx's kidney disease-related drug
Reuters
Tue, 10/17/23 - 09:59 pm
Ardelyx
chronic kidney disease
FDA
Xphozah
Novo Nordisk, with coffers filling with cash, buys rival to Bayer's kidney drug Kerendia in $1.3B deal
Fierce Biotech
Mon, 10/16/23 - 10:24 am
Novo Nordisk
KBP Biosciences
Bayer
chronic kidney disease
Kerendia
ocedurenone
hypertension
Novo Ends Semaglutide Kidney Study Early Due to Strong Efficacy Signals
BioSpace
Wed, 10/11/23 - 10:15 am
Novo Nordisk
semaglutide
clinical trials
diabetes
chronic kidney disease
FDA greenlights Jardiance for treating chronic kidney disease
Medical Marketing and Media
Fri, 09/22/23 - 11:50 am
Eli Lilly
Boehringer Ingelheim
Medicare
Jardiance
FDA
chronic kidney disease
Jardiance cleared in EU for CKD, challenging Forxiga
Pharmaphorum
Wed, 07/26/23 - 09:45 am
Boehringer Ingelheim
Eli Lilly
Jardiance
Europe
chronic kidney disease
Forxiga
GSK’s daprodustat obtains positive opinion from EMA CHMP
Pharmaceutical Business Review
Tue, 06/27/23 - 10:12 am
EMA
Europe
GSK
CHMP
daprodustat
chronic kidney disease
After breakup with Otsuka, Akebia finds new partner for oral anemia drug in Europe
Fierce Pharma
Thu, 05/25/23 - 01:07 pm
Akebia Therapeutics
Medice Arzneimittel Pütter
Europe
Australia
Vafseo
chronic kidney disease
Genexine's anemia drug matches Roche-CSL product in phase 3, laying groundwork for Asia filings
Fierce Biotech
Tue, 04/11/23 - 10:07 am
Genexine
chronic kidney disease
anemia
Roche
CSL Vifor
Mircera
Bayer study finds communication gap in managing chronic kidney disease in patients with type 2 diabetes
Medical Marketing and Media
Tue, 03/14/23 - 06:22 pm
Bayer
diabetes
chronic kidney disease
healthcare providers
physicians
Akebia's Appeal for Anemia in CKD Drug Delayed Again
BioSpace
Tue, 02/21/23 - 04:40 pm
Akebia Therapeutics
vadadustat
chronic kidney disease
GSK's oral anemia drug Jesduvroq scores partial FDA nod after 2 rivals suffered rejections
Fierce Pharma
Thu, 02/2/23 - 10:28 am
GSK
FDA
daprodustat
Jesduvroq
anemia
chronic kidney disease
FDA grants appeal for Ardelyx chronic kidney disease drug after July 2021 rejection
Endpoints
Fri, 12/30/22 - 10:40 am
Ardelyx
chronic kidney disease
FDA
tenapanor
Kidney Therapeutics to Halt CKD Progression, Make Late-Stage Push Toward NDA
BioSpace
Fri, 11/18/22 - 11:40 am
Kidney Therapeutics
chronic kidney disease
clinical trials
In surprise turn, FDA adcomm votes in favor of Ardelyx CKD drug despite agency questions
Endpoints
Wed, 11/16/22 - 11:30 pm
Ardelyx
FDA
chronic kidney disease
tenapanor

Pages